Benutzer: Gast  Login
Dokumenttyp:
Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial
Autor(en):
de Waha, Antoinette; Sandner, Sigrid; von Scheidt, Moritz; Boening, Andreas; Koch-Buettner, Katharina; Hammel, Dieter; Hambrecht, Rainer; Danner, Bernhard C; Schöndube, Friedrich A; Goerlach, Gerold; Fischlein, Theodor; Schmoeckel, Michael; Oberhoffer, Martin; Schulz, Rainer; Walther, Thomas; Ziegelhöffer, Tibor; Knosalla, Christoph; Schönrath, Felix; Beyersdorf, Friedhelm; Siepe, Matthias; Attmann, Tim; Misfeld, Martin; Mohr, Friedrich-Wilhelm; Sievers, Hans-Hinrich; Joost, Alexander; Putman, L...     »
Titel:
A randomized, parallel group, double-blind study of ticagrelor compared with aspirin for prevention of vascular events in patients undergoing coronary artery bypass graft operation: Rationale and design of the Ticagrelor in CABG (TiCAB) trial: An Investig
Abstract:
For patients with coronary artery disease undergoing coronary bypass surgery, acetylsalicylic acid (ASA) currently represents the gold standard of antiplatelet treatment. However, adverse cardiovascular event rates in the first year after coronary artery bypass grafting (CABG) still exceed 10%. Graft failure, which is predominantly mediated by platelet aggregation, has been identified as a major contributing factor in this context. Therefore, intensified platelet inhibition is likely to be benef...     »
Zeitschriftentitel:
Am Heart J
Jahr:
2016
Band / Volume:
179
Seitenangaben Beitrag:
69-76
Sprache:
eng
Volltext / DOI:
doi:10.1016/j.ahj.2016.05.017
PubMed:
http://view.ncbi.nlm.nih.gov/pubmed/27595681
Print-ISSN:
0002-8703
TUM Einrichtung:
Klinik für Herz- und Kreislauferkrankungen im Erwachsenenalter (Prof. Schunkert)
 BibTeX